Cell-free DNA measurable residual disease as a predictor of postallogeneic hematopoietic cell transplant outcomes.
Pasca S, Guo MZ, Wang S, Stokvis K, Shedeck A, Pallavajjala A, Shams C, Pallavajjala R, DeZern AE, Varadhan R, Gocke CD, Jones RJ, Gondek LP.
Pasca S, et al. Among authors: guo mz.
Blood Adv. 2023 Aug 22;7(16):4660-4670. doi: 10.1182/bloodadvances.2023010416.
Blood Adv. 2023.
PMID: 37276081
Free PMC article.